Hikma Pharmaceuticals PLC (LON: HIK)

Hikma Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	4,143	3,955	3,418	5,136	5,803	4,824
Market Cap Growth	15.72%	15.72%	-33.45%	-11.50%	20.30%	16.44%
Enterprise Value	4,907	4,766	4,383	5,569	6,208	5,109
Last Close Price	18.67	17.89	15.52	22.19	25.18	19.91
PE Ratio	27.98	26.81	22.26	16.63	18.98	13.18
PS Ratio	1.83	1.75	1.64	2.72	3.38	2.89
PB Ratio	2.39	2.28	1.92	2.82	3.69	3.00
P/FCF Ratio	12.02	11.48	10.51	14.11	27.13	18.10
P/OCF Ratio	8.29	8.29	7.77	10.90	17.07	13.54
EV/Sales Ratio	2.17	2.11	2.10	2.95	3.62	3.07
EV/EBITDA Ratio	7.73	7.68	7.88	10.50	12.96	11.59
EV/EBIT Ratio	10.10	9.81	10.61	13.44	15.69	13.92
EV/FCF Ratio	14.24	13.83	13.47	15.30	29.02	19.17
Debt / Equity Ratio	0.54	0.54	0.60	0.34	0.43	0.32
Debt / EBITDA Ratio	1.47	1.47	1.88	1.16	1.40	1.16
Debt / FCF Ratio	2.71	2.71	3.27	1.72	3.19	1.94
Asset Turnover	0.63	0.63	0.57	0.60	0.58	0.59
Inventory Turnover	1.76	1.76	1.70	1.72	1.70	2.02
Quick Ratio	0.82	0.82	1.05	1.31	1.05	0.82
Current Ratio	1.57	1.57	1.86	2.06	1.87	1.26
Return on Equity (ROE)	8.81%	8.81%	8.28%	18.20%	20.11%	25.46%
Return on Assets (ROA)	8.46%	8.46%	7.04%	8.24%	8.37%	8.18%
Return on Capital (ROIC)	11.33%	11.33%	9.23%	10.97%	11.45%	11.80%
Earnings Yield	3.57%	3.77%	4.57%	6.05%	5.44%	7.61%
FCF Yield	8.32%	8.71%	9.52%	7.09%	3.69%	5.53%
Dividend Yield	2.99%	3.16%	2.99%	1.80%	1.45%	1.67%
Payout Ratio	72.11%	72.11%	66.49%	28.50%	25.29%	19.96%
Buyback Yield / Dilution	1.13%	1.13%	3.47%	2.10%	2.06%	-0.41%
Total Shareholder Return	4.12%	4.29%	6.47%	3.90%	3.51%	1.26%

Source: S&P Capital IQ. Standard template.